The critical importance of CD8+ lymphocytes during chronic viral infection is well established, but their 18 roles in acute ZIKV infection remain incompletely explored. Importantly, antiviral CD8 responses could 19 modulate neurological manifestations that have accompanied recent ZIKV outbreaks. The rhesus 20 macaque model of ZIKV is a particularly valuable tool to understand immune mechanisms of ZIKV 21 control due to similarities in immune function to humans and due to their susceptibility to infection with 22 primary human isolates of the virus. In the present study, we infected four adult male rhesus macaques 23 with ZIKV, two of which had been depleted of CD8+ lymphocytes prior to infection. CD8 depletion 24 resulted in delayed viremia and a near absence of innate immune responses in the blood, demonstrated by 25 a complete lack of neutrophil recruitment to the blood and a striking absence of transcriptional changes in 26 type I interferon response and other key immune genes relative to non-depleted controls during acute 27 infection. Depletion also resulted in differential patterns of monocyte expansion and reduced monocyte 28 activation measured by CD169 expression. Notably, CD8-depleted macaques showed possible evidence 29
of compensatory CD4 T cell responses and persistence of neutralizing antibodies at later timepoints, 30 despite clearance of virus from serum. Neural lesions were also evident in both CD8-depleted animals.
31
One of the depleted animals recovered CD8+ lymphocytes by 21 days post-infection and mounted a high 32 magnitude CD8 T cell response against the virus. The other CD8-depleted animal did not recover CD8+
Introduction

38
Zika virus (ZIKV) has been a known pathogen for over half a century, but severe manifestations of 39 disease were not directly associated with the virus for most of its history. Although recent outbreaks of 40 ZIKV in the Western hemisphere are notorious for neurological complications including congenital Zika 41 syndrome (CZS) and Guillain-Barré syndrome (GBS), most cases remain asymptomatic, and when 42 symptoms arise, they are usually mild and self-limiting [1] . Differential immune responses to ZIKV 43 infection may dictate the severity of accompanying diseases and underlie clinical outcomes. 44
As the immunological correlates of protection against ZIKV are beginning to be explored, the CD8 T cell 45 response is emerging as an important frontline mediator of viral control, as is true with other flaviviruses.
46
Less is known about CD4 responses in acute ZIKV infection, although a recent study found that CD4 T 47 cells and IFN signaling are indispensable for effective humoral responses to ZIKV in mice [2] . CD8+ 48 lymphocyte depletion, which is a well-established immune manipulation in rhesus macaques [3] , is 49 therefore a plausible approach to gauge how the absence of CD8+ cells impacts acute viremia and 50 potentially induces surrogate adaptive responses. 51 CD8+ lymphocytes, including CD8 T cells and NK cells, are well known mediators of antiviral 52
immunity, but their roles in ZIKV infection and control have only been recently addressed. Studies in 53 mice have demonstrated CD8 T cell responses in ZIKV infection, but ZIKV-associated pathology in these 54 models requires deficiency in type-I interferon (IFN) signaling [4, 5] , which is not representative of 55 natural ZIKV infection in humans. This is perhaps an unavoidable caveat, as ZIKV is incapable of 56 antagonizing type-I IFN signaling in mice as it does in humans due to a lack of recognition of murine 57 STAT2 by ZIKV NS5 [2, 6] . Disrupting IFN-I signaling, either genetically or through antibody blockade, 58 is therefore necessary to recapitulate ZIKV neurotropism in mouse models. Importantly, these studies 59 have identified dual protective and deleterious effects of CD8 T cell responses in ZIKV infected animals 60 [4, 6] . While CD8+ lymphocyte infiltration of the CNS appears to reduce viral burden in the brain and 61 spinal cord [5] , CD8 influx also simultaneously promotes neural damage and hindlimb paralysis [6] . 62
However, these findings have yet to be replicated in a model sufficiently similar to humans genetically 63 and immunologically. Given the recent development [7] and characterization [8, 9] of a rhesus macaque 64 model for ZIKV, we sought to explore the role of CD8+ lymphocytes in acute ZIKV infection by way of 65 CD8+ lymphocyte depletion. 66
In the present study, we infected four adult male rhesus macaques, two of which had been previously 67 depleted of CD8+ lymphocytes, with a minimally passaged Brazilian ZIKV strain. The CD8-depleted 68 macaques showed striking virus-response patterns that were not evident in nondepleted macaques, 69 including delayed serum viremia, enhanced viral dissemination to peripheral tissues, and global 70 repression of antiviral gene transcription. CD8-depleted animals also manifested brainstem lesions that 71 were characterized by increased inflammation. Finally, the absence of CD8+ lymphocytes appeared to 72 alter patterns of monocyte expansion and activation and induce possible compensatory CD4 T cell and 73 humoral responses. 74
Results
75
Delayed serum viremia and altered leukocyte kinetics
76
CD8+ lymphocyte depletion commenced 14 days prior to ZIKV infection (Fig 1a) , and CD8 T cells were 77 undetectable in both treated animals as early as 11 days prior to ZIKV infection (Fig 1b) . Following 78 subcutaneous inoculation with ZIKV, nondepleted animals experienced a rapid spike in serum viremia of 79 3-4.5 logs at 1 dpi (Fig 1c) , consistent with previous reports of ZIKV in rhesus macaques [7, 10] . 80 Strikingly, serum viremia in CD8-depleted macaques was delayed by one day until 2 dpi, when viral 81 RNA was higher than in nondepleted animals (Fig 1c) . For the remainder of the study, viral kinetics were 82 similar among all animals, peaking at 3 dpi and dropping to undetectable levels by 10 dpi and beyond 83 (Fig 1c) . A previous cohort of female macaques infected with the identical strain of ZIKV demonstrated 84 similar patterns of serum viremia to those observed in nondepleted animals (Fig S1a) . 85
The previous female cohort also showed a remarkably consistent spike in neutrophil-to-lymphocyte ratio 86 (NLR), a biomarker of inflammation [11] , at 1 dpi (Fig S1c) . This pattern was replicated in nondepleted 87 animals, whereas the NLR in CD8-depleted animals did not elevate the day following infection (Fig 1d) , 88 potentially due to a slight decline in neutrophils ( Fig S1d) and lymphocytes remaining stagnant in 89 peripheral blood (Fig S1e) . 90
To achieve CD8 depletion, we used an antibody targeting CD8, which is expressed on both CD8 T cells 91 and NK cells. Thus, both cell populations were depleted in animals receiving antibody treatment. Flow 92 cytometric analysis of NK cells in nondepleted animals revealed proliferation early in infection (Fig 1e) .
93
Intriguingly, the CD8-depleted macaque HP17 recovered NK cells and CD8 cells at later timepoints, 94 between 15 and 21 dpi (Figs 1e & 1f) . 95
Quelled antiviral gene expression in whole blood
96
To further probe innate immune responses, we analyzed antiviral responses in whole blood using a qRT-97 PCR array of 84 antiviral genes in the rhesus macaque genome. Relative to expression levels pre-98 infection, nondepleted animals showed striking upregulation of several RIG-I like receptors and type-I 99 interferon (IFN) stimulated genes at 3 dpi, synchronous with peak serum viremia (Fig 2a) . The most 100 highly induced genes include the pattern recognition receptors TLR3, RIG-I (DDX58), and MDA5 101 (IFIH1), as well as the IFN-stimulated genes ISG15, MX1, and OAS2. Induction of these genes at 3 dpi 102 was generally followed by a return to near-baseline expression by 15 dpi. The gene expression profiles of 103 both nondepleted animals were remarkably similar ( Fig S2) . 104
In contrast to nondepleted animals, CD8-depleted animals showed an absence of transcriptional responses 105
in whole blood at all timepoints tested (Figs 2a and S2). However, CD86 was an exception to this pattern, 106 which was upregulated at 1, 3, and 15 dpi in GH01 but not in HP17 (Fig S2) . 107
Transcriptional analysis of whole blood revealed the general antiviral milieu in CD8-depleted and 108 nondepleted animals, but the identity of the transcriptionally responding immune cells remained elusive.
109
We suspected ZIKV-infected monocytes to be the main contributors to antiviral signaling owing to their 110 reported susceptibility to infection. However, the absence of a response in CD8-depleted macaques could 111 have been due to the lack of responding NK cells, which may contribute to antiviral signaling given their 112 responsiveness to type-I IFNs [12] . 113
To resolve the source of innate signaling, we separated the PBMCs from a nondepleted animal into CD8+ 114 from CD8-fractions and analyzed the expression of a few antiviral genes that we previously found to be 115 expressed in whole blood. We found similar levels of gene induction among both cell fractions, although 116 expression was slightly higher in the CD8-subset (Fig S3) . Additionally, transcription of DDX58 (RIG-I) 117 was almost exclusive to CD8-cells. 118
To further explore whether ZIKV-infected monocytes contribute to signaling within the CD8-fraction, 119
we cultured macrophages from monocytes in vitro, infected the macrophages with ZIKV, and probed 120 antiviral gene expression using a qRT-PCR array. We found highly overlapping transcriptional patterns to 121 those observed in the whole blood of nondepleted animals at 3 dpi (Fig 2b) . 122
Altered monocyte activation and frequency
123
The divergent transcriptional patterns in CD8-depleted and nondepleted macaques could have been due to 124 differential monocyte phenotypes, given the susceptibility of monocytes to ZIKV infection [13, 14] animals showed early activation of monocytes, which peaked at 3 dpi and returned sharply to baseline by 133 15 dpi (Fig 3a) . This pattern was present in all monocyte subsets (Fig S4a-c) . In contrast, CD8-depleted 134 animals showed a more prolonged trajectory of monocyte activation, persisting beyond 15 dpi. The 135 activation marker CD69 was also decreased on total monocytes in CD8-depleted animals early in 136 infection (Fig S4d) . 137 CD8 depletion also affected patterns of monocyte abundance. Nonclassical monocytes expanded 138 preferentially in CD8-depleted macaques (Fig 3b) , while the same was true of intermediate monocytes in 139 nondepleted animals (Fig 3c) . Nondepleted animals also showed expansion of classical monocytes at 1 140 dpi and then again at necropsy (Fig 3d) . 141 viSNE analysis revealed differential expression of CD95 (Fas) in CD8 depletion, which was found to be 142 significantly increased on nonclassical monocytes in CD8-depleted animals ( Fig S4e) and on classical 143 monocytes in GH01 at 10-15 dpi (Fig S4f) . To further characterize CD8 responses, we performed intracellular cytokine staining (ICS) of PBMCs 151 stimulated with peptides derived from the ZIKV proteome. Nondepleted macaques showed evidence of 152 CD8 T cell responses, which were co-positive for perforin and IFN (Fig 4c) . Further supporting CD8 153 responses in these animals, CD8 T cell frequency increased between 3 and 10 dpi (Fig 1f) , which 154 appeared to be driven by expansion of naïve and EM CD8 cells . Intriguingly, the CD8-155 depleted animal HP17 also mounted a CD8 T cell response at 21 dpi (Fig 4c) , soon after this animal 156 recovered CD8 cells (Fig 1f) . In all animals with CD8 cells present, CD8 T cell responses were greater at 157 the earlier of the two timepoints tested (Fig 4c) . 158
We also used ICS to explore possible compensatory CD4 responses in CD8-depleted macaques. Both 159 depleted animals showed evidence of antigen-specific Th1 responses at necropsy, characterized by co-160 positivity for IFN and IL-2 (Fig 4e) . These responses were also antigen-specific in both macaques, 161 preferential toward ZIKV E and NS1. GH01 exhibited moderate CD4 T cell responses at both timepoints 162 tested (15 and 30 dpi), whereas HP17 showed a robust response at 30 dpi alone. To gauge humoral responses to ZIKV, we conducted a plaque reduction neutralization test (PRNT) to 169 quantify neutralizing antibody titers in serum. All animals except JP58 showed evidence of neutralizing 170 antibodies at 7 dpi, the earliest post-infection timepoint tested (Fig 4f) . While all animals similarly 171 achieved highly neutralizing titers at 15 dpi, nondepleted animals receded in their antibody concentrations 172 beyond this timepoint. Strikingly, CD8-depleted animals retained high titers until necropsy, a finding 173 consistent with significantly higher rates of B cell proliferation in these animals (Fig 4g, +4 .0%, 174 0.004905). 175
Enhanced tissue dissemination and neuropathology
176
Given the maintenance of highly neutralizing antibody titers in CD8-depleted macaques, we suspected 177 that virus might be lingering in the peripheral tissues of these animals. Informed by previous reports of 178 ZIKV tropism in rhesus macaques [16, 17] , we searched for viral RNA in lymphoid, reproductive, and 179 neural tissues. 180 CD8-depleted macaques had significantly higher levels of viral RNA in the mesenteric lymph node 181 relative to nondepleted animals (Fig 5a) . Additionally, ZIKV was detectable in the cervical and inguinal 182 lymph nodes of all four animals but was most abundant in the CD8-depleted macaque HP17 (Fig 5a) . 183
Although all animals were negative for virus in the testes and prostate, GH01 manifested a high viral load 184 in semen at 21 dpi (Fig 5c) , the final timepoint obtained. ZIKV RNA was also detected in the seminal 185 vesicle of GH01 at necropsy (Fig 5a) . HP87 showed a minor amount of virus in the semen at 10 dpi, 186 which was cleared by 15 dpi (Fig 5c) . 187
We found no ZIKV RNA in the neural tissues of any animal (Fig 5a) . However, we also probed for ZIKV 188 RNA in cerebrospinal fluid (CSF) to further explore potential neural dissemination. All animals except 189 HP87 harbored virus in the CSF, peaking at 7-10 dpi (Fig 5b) , after serum viremia had waned. Notably, 190
the CSF viral loads in depleted macaques were over an order of magnitude greater than in nondepleted 191 animals. 192
Although ZIKV was not detected in the CNS of any animal, CD8-depleted macaques manifested neural 193 lesions that were not present in nondepleted animals. Most strikingly, the brainstem of GH01 showed an 194 area of severe multifocal to coalescing malacia, characterized by vacuolation, swollen axons, and 195 infiltration by lymphocytes and gitter cells (Fig 5d) . Gitter cells are occasionally found within dilated 196 myelin sheaths. Scant brown granular pigment (presumed hemosiderin) and a proliferative cerebral vessel 197 adjacent to the malacia may indicate that the malacia is the result of a vascular event (thromboemboli, 198 infarct, ischemia, etc.) . 199
No gross abnormalities were noted in HP17. However, the sciatic nerve of this animal exhibited mild 200 lymphocytic perivasculitis, and the brainstem contained a localized area of gliosis and dilated myelin 201 sheaths (Fig 5e) . A cause for these neural inflammatory lesions was not apparent by histology. 202
Discussion
203
Owing to the importance of CD8+ T cells in control of ZIKV in mice [4, 5] Despite the absence of ZIKV RNA in the brain of any animal, both CD8-depleted macaques presented 292 with neural lesions at necropsy that were not evident in nondepleted animals. Although the lesions cannot 293 be directly attributed to ZIKV infection, our observations are consistent with pathological manifestations 294 of ZIKV in mice and humans. The most severe lesion was in the brainstem of GH01, the CD8-depleted 295 animal that never recovered CD8 cells. We noted an extensive region of encephalomalacia which showed 296 evidence of Wallerian degeneration, characterized by swollen axons and infiltration of phagocytic gitter 297 cells. Importantly, similar manifestations have been described in ZIKV infection of human fetal brain 298 tissue [28, 29] . 299
Neural lesions in HP17 were less severe, and interestingly, this animal also recovered CD8 cells and 300 mounted CD8 T cell responses during infection. The sciatic nerve of HP17 exhibited mild inflammation, 301 a location that ZIKV has previously been identified in mice depleted of CD8 cells [4] . Also, the brainstem 302 contained glial nodules, which are an indicator of CNS damage that can be seen in viral encephalitis 303
Although it is tempting to speculate that CD8 depletion in GH01 and HP17 promoted neural 304 dissemination of ZIKV and consequent pathological sequalae, our inability to detect viral RNA precludes 305 this conclusion. Because the virus was cleared from the CNS within 30 dpi, it is possible that these 306 lesions could still be virus associated even if viral RNA was not detectable in these lesions at the time of 307 necropsy. It is worth noting that CNS localization of ZIKV has been observed as early as 5 dpi in acutely 308 infected macaques [10] . Separately, a recent study of acute ZIKV infection in rhesus macaques failed to 309 identify ZIKV RNA in the CNS at 14 dpi, despite diffuse patterns of viral dissemination [17] . These 310 findings establish precedence for early CNS dissemination of ZIKV in nonhuman primates, which may be 311 cleared later in infection. 312
In CD8-depleted animals, the absence of NK and CD8 T cell surveillance could have facilitated ZIKV Two animals (GH01 and HP17) were depleted of CD8+ lymphocytes by administration of the anti-CD8 333 antibody MT807R1 (NHP Reagent Resource; https://www.nhpreagents.org) [3] . Four administrations of 334 5-10 mg/kg were given subcutaneously or intravenously at days 14, 11, 7, and 10 days pre-infection, as 335 per the distributor's protocol. All four animals were subcutaneously infected with 10 4 PFU of a Brazilian 336 ZIKV isolate at 0 dpi (Fig 1a) . For data comparison, we included viral loads and CBC data from a 337 previous cohort of 4 non-pregnant female rhesus macaques (CJ89, GA04, HE78, and JD24) that were 338 similarly infected with the same dose of the same Brazilian ZIKV isolate as was used in this study. 339
Whole blood, CSF, and semen were obtained from animals at the indicated timepoints. Peripheral blood 340 mononuclear cells (PBMCs) were isolated using SepMate tubes (Stemcell Technologies) according to the 341 manufacturer's protocol. At necropsy, the indicated tissues were collected and snap-frozen. 342
Virus quantification
343
Viral RNA (vRNA) was extracted from serum and CSF using the High Pure Viral RNA Kit (Roche). 344
Semen, as well as the indicated lymphoid, reproductive, and neural tissues were homogenized in Qiazol 345 (Qiagen) using disposable tissue grinders (Fisherbrand), and RNA was isolated using the RNeasy Lipid 346
Tissue Mini Kit (Qiagen). vRNA from body fluids and tissues was quantified using qRT-PCR as 347 described previously [8] . 348 Antiviral gene expression assays 349 2.5 ml whole blood was drawn from each animal at 0, 1, 3, and 15 dpi into PAXgene blood RNA tubes 350 (PreAnalytiX) and equilibrated to -80˚C as per the manufacturer's protocol. RNA was extracted from 351 blood samples using the PAXgene blood RNA kit (PreAnalytiX), and cDNA was synthesized using the 352 RT2 First Strand Kit (Qiagen). The rhesus macaque antiviral response was analyzed by way of qRT-PCR 353 using RT2 Profiler PCR Arrays (Qiagen). 354
To identify cells contributing to antiviral signaling in blood, the CD8 microbead kit (Miltenyi Biotec) was 355 used to separate CD8+ from CD8-fractions in PBMCs from the nondepleted animal JP58 at peak 356 transcriptional activity (3 dpi). RNA was isolated from cell fractions using the RNeasy Mini Kit (Qiagen), 357 and cDNA was synthesized using the RT2 First Strand Kit (Qiagen). RT2 qPCR Primer Assays (Qiagen)  358 were used to analyze expression of ISG15, OAS2, and DDX58 relative to b-actin (ACTB) in CD8+ and 359
CD8-fractions. 360
To characterize antiviral signaling in myeloid cells, PBMCs were isolated from the whole blood of 4 361 naïve colony rhesus macaques as described above, and CD14 microbeads (Miltenyi Biotec) were used to 362 isolate monocytes. Monocytes were cultured at 1 × 10 cells/ml in RPMI-1640 medium supplemented 363 with 1% human AB serum (Sigma), 20 ng/ml M-CSF (Peprotech), 1% L-glutamine, and 1% 364 penicillin/streptomycin. After 7 days of culture, monocytes were sufficiently differentiated into 365 macrophages and were infected with the same Brazilian ZIKV isolate described above. At 24 hpi, RNA 366 was extracted using the RNeasy Mini Kit (Qiagen), and qRT-PCR arrays were used to analyze rhesus 367 antiviral signaling as described previously. 368
Flow cytometry and gating strategy 369
PBMCs from the indicated timepoints were thawed, washed, and stained using Live/Dead Fixable Aqua 370
Dead Cell Stain Kit (Invitrogen). PBMCs were then stained for the surface markers CD16 (AL488; 371 BioLegend), CD169 (PE; BioLegend), CD28 (PECF594; BD Biosciences), CD95 (PCP-Cy5.5; 372 BioLegend), CD3 (PE-Cy7; BD Biosciences), CD8 (PacBlue; BioLegend), CD14 (BV605; BD 373 Biosciences), HLA-DR (BV650; BioLegend), NKG2A (APC; Beckman Coulter), and CD4 (APC-H7; 374 BD Biosciences). Cells were subsequently fixed in FluoroFix buffer (BioLegend), permeabilized using 375
Perm/Wash buffer (BioLegend), and stained intracellularly for CD69 (BV711; BD Biosciences) and Ki67 376 (AL700; BD Biosciences). Flow cytometry was performed on a BD LSRII instrument and data were 377 analyzed using FlowJo (vX.10.4.2) and viSNE (Cytobank) softwares. 378
Cytometry data were first gated for lymphocytes, singlets, and live cells. NK cells were considered as 379 CD8+/CD16+. CD4 T cells (CD3+/CD4+) and CD8 T cells (CD3+/CD8+) were gated into naïve 380 (CD28+/CD95-), central memory (CD28+/CD95+), and effector memory (CD28-/CD95+) subsets. CD3-381 cells were divided into B cells (DR+/CD14-/CD16-) and monocytes (classical, CD14++/CD16-; 382 intermediate, CD14+/CD16+; nonclassical, CD14 low /CD16+). Cell subsets were analyzed with respect to 383 frequency, proliferation (Ki67+) and activation (CD69+ or CD169+). 384
Intracellular cytokine staining
385
PBMCs from the indicated timepoints were thawed and rested overnight prior to stimulation with peptide 386 pools comprising ZIKV C, M, E, and NS1 (BEI Resources). On peptide stimulation, cells were also 387 treated with brefeldin A (BioLegend), GolgiStop (BD Biosciences), anti-CD28 (NHP Reagent Reference 388
Program, www.nhpreagents.org/), anti-CD49d (BioLegend), and anti-CD107a (AL700; BD Biosciences). 389 24 hours post-stimulation, cells were stained for the surface markers CD3 (PE-Cy7; BD Biosciences), 390 CD8 (PacBlue; BioLegend), and CD4 (APC-H7; BD Biosciences). Cells were also fixed and 391 permeabilized as described above and stained intracellularly for perforin (FITC; Mabtech), granzyme B 392 (PE; Invitrogen), CD69 (PE-CF594; BD Biosciences), IL-2 (PCP-Cy5.5; BD Biosciences), and IFN 393 (AL647; BioLegend). Flow cytometry was performed on a BD LSRII instrument and data were analyzed 394 using FlowJo software (vX.10.4.2). 395
Plaque reduction neutralization tests
396
ZIKV PRNTs were conducted according to previously published protocols [32, 33] . Briefly, ZIKV MEX-397 I-44 isolated in Tapachula, Mexico in 2016 was obtained from The University of Texas Medical Branch, 398
Galveston, TX and cultured to passage 8 in Vero cells. Serum specimens were incubated for one hour at 399 serial dilutions of 1:10, 1:20… 1:320 with previously frozen virus stock of know plaque forming unit 400 (PFU). Samples were then inoculated in duplicate onto a mono-layer of Vero cells grown on 6-well 401 plates and allowed to incubate for an additional hour. Infectious material was then removed and replaced 402 with a 1:1 mixture of Vero media and Avicel® before being incubated for 4 days. To read plaques, the 403
Avicel® layer was fixed with 10% neutral buffered formalin. Finally, the formalin-Avicel® layer was 404 removed and the monolayer was stained with crystal violet, washed with tap water and allowed to dry 405 before plaques were counted manually. 406
Percent reduction in observed plaques and a PRNT90 cutoff were used for interpretation. A PRNT90 titer 407 is the dilution of a sample at which a 90% reduction in possible plaques is observed. The maximum 408 number of potential plaques was obtained for each run using a corresponding back-titration and a linear 409 model was fit to the observed number of plaques for each dilution. A PRNT90 titer was derived for each 410 sample using the linear model and the equation for a straight line in the statistical program R [34] . For 411 samples that were positive but above the resolution of the PRNT assay the value of the greatest number of 412 possible plaques for that run, as determined by the back titration, was assigned for each dilution for use 413 with the linear model. 414
Histology
415
Tissues samples collected at necropsy were fixed in Z-Fix (Anatech), embedded in paraffin and 5μm 416 thick sections were cut, adhered to charged glass slides, and either stained routinely with hematoxylin and 417 eosin or Prussian blue. 418
Statistical analysis
419
For viral loads, Mann-Whitney U tests were performed using GraphPad Prism v6.07 (GraphPad 420 Software). For immune cell phenotyping, linear mixed model analyses were performed using R statistical 421
computing [34] with the lme4 package [35] . Animal variation was considered a random effect, while 422 fixed effects included CD8 depletion, dpi, and expression level of the marker in question. P-values were 423 calculated using likelihood ratio tests of the full model against a reduced model lacking the effect of CD8 424 depletion. 425
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